Coexisting Diseases & Surgery
58
Quality Score
Solid
✍️ Bumetric analysis
“
Coexisting Diseases & Surgery is an iOS app from Vargo Anesthesia Inc in the Education category, currently rated 4.5★ across 28 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 58: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
→
12-mo forecast
$5.2K – $10.8K
per month
→
24-mo forecast
$6.4K – $19.2K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
16 snapshots on record
Rating
4.5
Reviews
28 reviews
Forecast Revenue / mo
$5.0K
Snapshots tracked
16
since Dec 2020
ONE-TIME · BUILD
💰 Estimated build cost
$145K
↳ What it cost to build · not monthly revenue
Likely range $110K – $195K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~2.4y at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (212 MB) | +$40K |
| ⚙ Education complexity ×1.20 | +$18K |
| ⚙ 5.9y maintenance × ~1-person team | +$35K |
Total estimate
$145K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$100K
↳ What it would sell for · not monthly revenue
Marketplace range $75K – $125K · 19× MRR multiple
💸
~0.7× build cost (under-water)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 📅 5.9y proven track record | +20% |
| ⭐ ★ rating ≥ 4.4 (solid) | +8% |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
19× MRR
🛠 Estimated tech stack
🍎
Native iOS (SwiftUI)
Medium confidence · 55%
Also possible
React Native
Flutter
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
Signals we read
| 📦 App bundle size | 212 MB |
| 🏷 Category context | Education |
| 📦 Large iOS bundle | → Native SwiftUI (post-2020 era) + assets |
💀 Maintenance status
Slowing
25%
Last shipped 2026-08-05 · 82 days ago
0 · Active
50 · At risk
100 · Abandoned
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
Risk signals
| 📅 82 days since last update | Healthy release cadence |
| 👥 Small user base (28 ratings) + 5.9y old | +10% (solo-project pattern) |
Verdict
Slowing
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 46/100MID TIERunderperforming peersRevenue Strength
3.7
Product Quality
3.6
Market Position
2.0
Growth Velocity
5.0
Defensibility
5.0
Operational Safety
10.0
Founder Strength
6.5
Monetization Maturity
1.0
- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.54★ across 28 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K. Portfolio play ($57K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($99.99)METRIC | +$2,800 | |
| Excellent rating (4.5★)METRIC | +$2,200 | |
| highly recommendREVIEW | +$1,400 | |
| Established app (5y old)METRIC | +$800 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (28 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · vDescription, images disclaimer updated
App Description, disclaimer, and images updated
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Coexisting Diseases & Surgery
- Developer
- Vargo Anesthesia Inc
- Bundle ID
- com.vargo.coex
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $5.0K/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth29 ratings+1350% lifetimeShow 3-year history estimate ▾
Tracked (16 weeks) Pre-tracking estimate (0 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
💰Pricing History$99.99 → $99.99 (+0%)
🚀Update Frequency · Releases per Quarter3 releases tracked
🚀Version Release Timeline3 releases tracked
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
The Vargo Coexisting Diseases & Surgery App is a clinician-built resource designed to help anesthesia providers tailor anesthetic management to the patient’s underlying comorbidities and surgical considerations. Built from years of clinical experience, the app focuses on how coexisting diseases directly impact perioperative decision-making.
Organized by major clinical systems, the app allows for rapid access to condition-specific anesthesia considerations—whether preparing for a case or managing complex patients in active clinical settings.… View full description on the official store →
Organized by major clinical systems, the app allows for rapid access to condition-specific anesthesia considerations—whether preparing for a case or managing complex patients in active clinical settings.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 212 MB🔞 17+📱 iOS 13+🔖 vDescription, images disclaimer updated🔄 updated 2mo ago🌐 EN📂 Education💰 Paid🚀 Launched 2020 (5y old)
📅
What Worked™ · Development Pipeline
9 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-08
🔧
Shipped update — v2.0.2 → vDescription, images disclaimer updated
2026-06
💲
Price ↑ $79.99 → $99.99 (+25%)
2026-05
🔧
Shipped update — v1.9.9 → v2.0.2
2026-05
💲
Price ↓ $99.99 → $79.99 (-20%)
2026-03
💲
Went paid — introduced $99.99 price point
2022-11
📈
Crossed 10 ratings — social-proof flywheel kicking in
→ 30 days after: revenue +$251/mo · rating −0.25★ high confidence
2021-05
⭐
Rating ↓ 5.00 → 4.40 (dropped 0.60★)
2020-12
🚀
First tracked snapshot — initial data captured
→ 30 days after: revenue +$627/mo medium · co-occurring
2020-12
🚀
First tracked snapshot — initial data captured
→ 30 days after: revenue +$627/mo medium · co-occurring
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇺🇸 US | 4.55172★ | 29 | 4.55172★ this version |
| 🇬🇧 GB | 0★ | 0 | — |
| 🇩🇪 DE | 0★ | 0 | — |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇨🇦 CA | 0★ | 0 | — |
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇮🇳 IN | 0★ | 0 | — |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by Vargo Anesthesia Inc
View all →📦 Portfolio summaryINDIE studio
4apps·$20K/mocombined
✓ Diversified — top app contributes 25%; risk spread across portfolio
About this analysis
Why low confidence: only 28 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Coexisting Diseases & Surgery is a small / niche iOS app in the education space with weak public traction — only 28 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
7 answers · auto-generated from this app's public dataHow much does Coexisting Diseases & Surgery make per month?▴
Our model estimates Coexisting Diseases & Surgery earns roughly $5.0K/mo, but with only 28 ratings the confidence interval is wide. No founder-verified MRR is available for this app, so this is a model output calibrated against comparable apps in the same category. See methodology for the formula.
What apps are like Coexisting Diseases & Surgery?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is Coexisting Diseases & Surgery built with?▴
Our heuristic places Coexisting Diseases & Surgery on the Native iOS (SwiftUI) stack (Medium confidence, 55%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: React Native, Flutter.
Is Coexisting Diseases & Surgery still actively maintained?▴
Maintenance status: Slowing (25% abandonment risk). Last shipped version was 2 months ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
When was Coexisting Diseases & Surgery last updated?▴
Coexisting Diseases & Surgery last shipped a new version on 2026-08-05 — 2 months ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes Coexisting Diseases & Surgery?▴
Coexisting Diseases & Surgery is published by Vargo Anesthesia Inc on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Coexisting Diseases & Surgery's BU Score?▴
Coexisting Diseases & Surgery has a BU Score of 58/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.